Cargando…

An optimized peptide vaccine strategy capable of inducing multivalent CD8(+) T cell responses with potent antitumor effects

Therapeutic cancer vaccines are an attractive alternative to conventional therapies for treating malignant tumors, and successful tumor eradication depends primarily on obtaining high numbers of long-lasting tumor-reactive CD8(+) T cells. Dendritic cell (DC)-based vaccines constitute a promising app...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Hyun-Il, Jung, Soo-Hyun, Sohn, Hyun-Jung, Celis, Esteban, Kim, Tai-Gyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589052/ https://www.ncbi.nlm.nih.gov/pubmed/26451316 http://dx.doi.org/10.1080/2162402X.2015.1043504

Ejemplares similares

CD4 T cells transduced with CD80 and 4-1BBL mRNA induce long-term CD8 T cell responses resulting in potent antitumor effects
por: Cho, Hyun-Il, et al.
Publicado: (2014)

T Cells Modified with CD70 as an Alternative Cellular Vaccine for Antitumor Immunity
por: Lee, Sang-Eun, et al.
Publicado: (2020)

Co-expression of CD40L with CD70 or OX40L increases B-cell viability and antitumor efficacy
por: Shin, Chang-Ae, et al.
Publicado: (2016)

CD40 ligand stimulation affects the number and memory phenotypes of human peripheral CD8(+) T cells
por: Choi, Haeyoun, et al.
Publicado: (2023)

Simultaneous in vitro generation of CD8 and CD4 T cells specific to three universal tumor associated antigens of WT1, survivin and TERT and adoptive T cell transfer for the treatment of acute myeloid leukemia
por: Sohn, Hyun-Jung, et al.
Publicado: (2017)

Measurement of CD8(+) and CD4(+) T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCs
por: Sohn, Dae-Hee, et al.
Publicado: (2015)

Comprehensive Analysis of Cytomegalovirus pp65 Antigen-Specific CD8(+) T Cell Responses According to Human Leukocyte Antigen Class I Allotypes and Intraindividual Dominance
por: Hyun, Seung-Joo, et al.
Publicado: (2017)

Multivalent Carbohydrate Nanocomposites for Tumor Microenvironment Remodeling to Enhance Antitumor Immunity
por: Hyun, Gyu Hwan, et al.
Publicado: (2023)

An effective peptide vaccine strategy circumventing clonal MHC heterogeneity of murine myeloid leukaemia
por: Shin, A-Ri, et al.
Publicado: (2020)

Enhanced Induction of T Cell Immunity Using Dendritic Cells Pulsed with HIV Tat and HCMV-pp65 Fusion Protein In Vitro
por: Park, Jung-Sun, et al.
Publicado: (2011)

Comprehensive Analysis of Epstein-Barr Virus LMP2A-Specific CD8(+) and CD4(+) T Cell Responses Restricted to Each HLA Class I and II Allotype Within an Individual
por: Jo, Hyeong-A, et al.
Publicado: (2022)

Helper cell-independent antitumor activity of potent CD8(+) T cell epitope peptide vaccines is dependent upon CD40L
por: Llopiz, Diana, et al.
Publicado: (2013)

Comprehensive Analysis of CD4(+) T Cell Responses to CMV pp65 Antigen Restricted by Single HLA-DR, -DQ, and -DP Allotype Within an Individual
por: Hyun, You-Seok, et al.
Publicado: (2021)

Resolution of Eczema with Multivalent Peptides
por: Eggink, Laura L., et al.
Publicado: (2022)

Effective antitumor peptide vaccines can induce severe autoimmune pathology
por: Sultan, Hussein, et al.
Publicado: (2017)

Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2
por: Gaynor, Katherine U., et al.
Publicado: (2023)

The natural compound gracillin exerts potent antitumor activity by targeting mitochondrial complex II
por: Min, Hye-Young, et al.
Publicado: (2019)

Discovery of a novel potent peptide agonist to adiponectin receptor 1
por: Kim, Sunghwan, et al.
Publicado: (2018)

Local and Systemic Injections of Human Cord Blood Myeloid-Derived Suppressor Cells to Prevent Graft Rejection in Corneal Transplantation
por: Lee, Jae-young, et al.
Publicado: (2022)

Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial
por: Kim, Hee-Je, et al.
Publicado: (2018)

Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugate
por: Puthenveetil, Sujiet, et al.
Publicado: (2017)

A novel Epstein–Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy
por: Cho, Hyun-Il, et al.
Publicado: (2018)

Regulation of CD4(+)CD8(−)CD25(+) and CD4(+)CD8(+)CD25(+) T cells by gut microbiota in chicken
por: Lee, In Kyu, et al.
Publicado: (2018)

Allogeneic dendritic cells induce potent antitumor immunity by activating KLRG1(+)CD8 T cells
por: Wang, Chao, et al.
Publicado: (2019)

Graphene-Iodine Nanocomposites: Highly Potent Bacterial Inhibitors that are Bio-compatible with Human Cells
por: Some, Surajit, et al.
Publicado: (2016)

Local Myeloid-Derived Suppressor Cells Impair Progression of Experimental Autoimmune Uveitis by Alleviating Oxidative Stress and Inflammation
por: Lee, Jae-Young, et al.
Publicado: (2023)

In Vitro Expansion of Vδ1+ T Cells from Cord Blood by Using Artificial Antigen-Presenting Cells and Anti-CD3 Antibody
por: Hur, Gaeun, et al.
Publicado: (2023)

Comprehensive analysis of mycobacterium tuberculosis antigen-specific CD4(+) T cell responses restricted by single HLA class II allotype in an individual
por: Lee, Yong-Hun, et al.
Publicado: (2022)

CD8α+ dendritic cells potentiate antitumor and immune activities against murine ovarian cancers
por: Lee, Shin-Wha, et al.
Publicado: (2023)

Comprehensive Analysis of CD4(+) T Cell Response Cross-Reactive to SARS-CoV-2 Antigens at the Single Allele Level of HLA Class II
por: Hyun, You-Seok, et al.
Publicado: (2022)

Embryonic Fibroblasts Promote Antitumor Cytotoxic Effects of CD8(+) T Cells
por: Qin, Yingyu, et al.
Publicado: (2018)

Analysis of binding properties of pathogens and toxins using multivalent glycan microarrays
por: Kim, Hyoung Sub, et al.
Publicado: (2018)

T-bet promotes potent antitumor activity of CD4(+) CAR T cells
por: Gacerez, Albert T, et al.
Publicado: (2018)

A Multivalent Vaccine Based on Ferritin Nanocage Elicits Potent Protective Immune Responses against SARS-CoV-2 Mutations
por: Kim, Seong A., et al.
Publicado: (2022)

A potent multivalent vaccine for modulation of immune system in atherosclerosis: an in silico approach
por: Karkhah, Ahmad, et al.
Publicado: (2016)

Harnessing novel engineered feeder cells expressing activating molecules for optimal expansion of NK cells with potent antitumor activity
por: Min, Bokyung, et al.
Publicado: (2021)

Synthetic Multivalent Antifungal Peptides Effective against Fungi
por: Lakshminarayanan, Rajamani, et al.
Publicado: (2014)

Impact of multivalent charge presentation on peptide–nanoparticle aggregation
por: Schöne, Daniel, et al.
Publicado: (2015)

Multivalent Peptide–Nanoparticle Conjugates for Influenza‐Virus Inhibition
por: Lauster, Daniel, et al.
Publicado: (2017)

Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity
por: Garrido, Greta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o00fr0lsor0aq6ucu74fv5fhhv